National heart, lung, and blood institute workshop on sodium and blood pressure: A critical review of current scientific evidence

Hypertension

Volumn 35, Issue 4, 2000, Pages 858-863

  Chobanian, Aram V ^a   Hill, Martha ^b,c   Roccella, Edward J ^c  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF NURSING   (United States)

^c NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

Blood pressure; Cardiovascular diseases; Sodium

Indexed keywords

BLOOD PRESSURE MEASUREMENT; BODY WEIGHT; DIET RESTRICTION; HUMAN; HYPERTENSION; MEDICAL RESEARCH; PRIORITY JOURNAL; REVIEW; SODIUM INTAKE; WATER RETENTION;

EID: 0034024637     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.35.4.858     Document Type: Review

References (56)

1. Cutler JA, Kotchen TA, Obarzanek E, eds. The National Heart, Lung, and Blood Institute Workshop on Salt, and Blood Pressure. Hypertension. 1991;17:I1-121.
2. National High Blood Pressure Education Program. Working group report on primary prevention of hypertension. Arch Intern Med. 1993;153:186-208.
3. National Heart, Lung, and Blood Institute. Implementing Recommendations for Dietary Salt Reduction: Where Are We? Where Are We Going? How Do We Get There?: A Summary of an NHLBI Workshop. Bethesda, Md: National Institutes of Health; 1996. Publication No. (NIH) 55-728 N.
4. Tobian L. Lessons from animal models that relate to human hypertension. Hypertension. 1991;17(suppl I):I-52-I-58.
5. Demon D, Weisinger R, Mundy NI, Wickings EJ, Dixson A, Moisson P, Pingard AM, Shade R, Carey D, Ardaillou R, Paillard F, Chapman J, Thillet J, Michel JB. The effect of increased salt intake on blood pressure of chimpanzees. Nat Med. 1995;1:1009-1016.
6. He J, Tell GS, Tang YC, Mo PS, He GQ. Relation of electrolytes to blood pressure in men. Hypertension. 1991;17:378-385.
7. The Trials of Hypertension Prevention Collaborative Research Group. Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high-normal blood pressure: the Trials of Hypertension Prevention, Phase II. Arch Intern Med. 1997;157:657-667.
8. Whelton PK, Appel LJ, Espeland MA, Applegate WB, Ettinger WH Jr, Kostis JB, Kumanyika S, Lacy CR, Johnson KC, Folmar S, Cutler JA. Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE): TONE Collaborative Research Group. JAMA. 1998;279:839-846.
9. Zoccali C, Mallamaci F, Cuzzola F, Leonardis D. Reproducibility of the response to short-term low salt intake in essential hypertension. J Hypertens. 1996;14:1455-1459.
10. Whelton PK, HE J, Cutler JA, Brancati FL, Appel LJ, Follmann D, Klag MJ. Effects of oral potassium on blood pressure: meta-analysis of randomized clinical trials. JAMA. 1997;277:1624-1632.
11. Weinberger MH, Fineberg NS. Sodium and volume sensitivity of blood pressure: age and pressure change over time. Hypertension. 1991;18:67-71.
12. Allender PS, Cutler JA, Follmann D, Cappuccio FP, Pryer J, Elliott P. Dietary calcium and blood pressure: a meta-analysis of randomized clinical trials. Ann Intern Med. 1996;124:825-829.
13. Bucher HC, Cook RJ, Guyatt GH, Lang JD, Cook DJ, Hatala R, Effects of dietary calcium supplementation on blood pressure: a meta-analysis of randomized controlled trials. JAMA. 1996;275:1016-1022. [Published letter appears in JAMA. 1996;276:1386 and Ann Intern Med. 1997; 126:493.]
14. Bucher HC, Cook RJ, Guyatt GH, Lang JD, Cook DJ, Hatala R, Effects of dietary calcium supplementation on blood pressure: a meta-analysis of randomized controlled trials. JAMA. 1996;275:1016-1022. [Published letter appears in JAMA. 1996;276:1386 and Ann Intern Med. 1997; 126:493.]
15. Bucher HC, Cook RJ, Guyatt GH, Lang JD, Cook DJ, Hatala R, Effects of dietary calcium supplementation on blood pressure: a meta-analysis of randomized controlled trials. JAMA. 1996;275:1016-1022. [Published letter appears in JAMA. 1996;276:1386 and Ann Intern Med. 1997; 126:493.]
16. Mizushima S, Cappuccio FP, Nichols R, Elliott P. Dietary magnesium intake and blood pressure: a qualitative overview of the observational studies. J Hum Hypertens. 1998;12:447-453.
17. Yamamoto ME, Applegate WB, Klag MJ, Borhani NO, Cohen JD, Kirchner KA, Lakatos E, Sacks FM, Taylor JO, Hennekens CH. Lack of blood pressure effect with calcium and magnesium supplementation in adults with high-normal blood pressure: results from Phase I of the Trials of Hypertension Prevention (TOPH). Ann Epidemiol. 1995;5:96-107.
18. Sacks FM, Willett WC, Smith A, Brown LE, Rosner B, Moore TJ. Effect on blood pressure of potassium, calcium, and magnesium in women with low habitual intake. Hypertension. 1998;31(pt 1):131-138.
19. Sacks FM, Obarzanek E, Windhauser MM, Svetkey LP, Vollmer WW, McCullough M, Karanja NM, Lin P-H, Steele P, Proschan MA, Evans MA, Appel LJ, Bray GA, Vogt TM, Moore TJ. Rationale and design of the Dietary Approaches to Stop Hypertension (DASH 2). Ann Epidemiol. 1995;5:108-118.
20. Appel LJ, Moore FJ, Obarzanek E, Vollmer WM, Svetkey LP, Sacks FM, Bray GA, Vogt TM, Cutler JA, Windhauser MM, Lin P-H, Karanja N. A clinical trial of the effects of dietary patterns on blood pressure. N Engl Med. 1997;336:117-1124.
21. Svetkey LP, Simons-Morton D, Vollmer WM, Appel LJ, Conlin PR, Ryan DH, Ard J, Kennedy BM. Effects of dietary patterns on blood pressure: subgroup analysis of the Dietary Approaches to Stop Hypertension (DASH) randomized clinical trial. Arch Intern Med. 1999;159:285-293.
22. Karanja N, Obarzanek E, Lin P-H, McCullough M, Phillips KM, Swain JF, Champagne CM, Hoben KP. Descriptive characteristics of the dietary patterns used in the Dietary Approaches to Stop Hypertension trial. J Am Diet Assoc. 1999;99(suppl):S19-S27.
23. Simons-Morton DG, Obarzanek E. Diet and blood pressure in children and adolescents. Pediatr Nephrol. 1999;11:244-249.
24. Falkner B, Michel S. Blood pressure response to sodium in children and adolescents. Am J Clin Nutr. 1997;65(suppl):618S-621S.
25. Geleijnse JM, Hofman A, Witteman JC, Hazebroek AA, Valkenburg HA, Grobbee DE. Long-term effects of neonatal sodium restriction on blood pressure. Hypertension. 1997; 29:913-917 [Published erratum appears in Hypertension. 1997;29:1211.]
26. Geleijnse JM, Hofman A, Witteman JC, Hazebroek AA, Valkenburg HA, Grobbee DE. Long-term effects of neonatal sodium restriction on blood pressure. Hypertension. 1997; 29:913-917 [Published erratum appears in Hypertension. 1997;29:1211.]
27. Midgley JP, Matthew AG, Greenwood CM, Logan AG. Effect of reduced dietary sodium on blood pressure: a meta-analysis of randomized controlled trials. JAMA. 1996;275:1590-1597.
28. Cutler JA, Follmann D, Allender PS. Randomized trials of sodium reduction: an overview. Am J Clin Nutr. 1997;65(suppl):643S-651S.
29. Graudal NA, Galloe AM, Garred P. Effects of sodium restriction on blood pressure, renin, aldosterone, catecholamines, cholesterols, and triglyceride: a meta-analysis. JAMA. 1998;279:1383-1389.
30. Ganguli MC, Grimm RH, Svendsen KH, Flack JM, Grandits GA, Elmer PJ. Higher education and income are related to a better Na:K ratio in blacks: baseline results of the treatment of mild hypertension study (TOMHS) data. Am J Hypertens. 1997;10:979-984.
31. Cutler JA, Grandits G. What have we learned about socioeconomic status and cardiovascular disease from large clinical trials? In: Report of the Conference on Socioeconomic Status and Cardiovascular Health and Disease. Bethesda, Md; National Institutes of Health; 1995.
32. Kumanyika SK, Hebert PR, Cutler JA, Lasser VI, Sugars CP, Steffen-Batey L, Brewer AA, Cameron M, Shepek LD, Cook NR, Miller ST. Feasibility and efficacy of sodium reduction in the Trials of Hypertension Prevention, Phase I. Hypertension. 1993; 22:502-512.
33. Rahman M, Bowlin S, Wright J, Scarpa A, Wu G, Fetheroff S, Hernton R, Douglas J. Erythrocyte sodium transport in human salt sensitive hypertension. Am J Hypertens. 1997;10:41A. Abstract.
34. Jeffery RW, Pirie PL, Elmer PJ, Bjornson-Benson WM, Mullenbach VA, Kurth CL, Johnson SL. Low-sodium, high-potassium diet: feasibility and acceptability in a normotensive population. Am J Public Health. 1984;74:492-494.
35. Grimm RH Jr, Grandits GA, Cutler JA, Stewart AL, McDonald RH, Svendsen K, Prineas RJ, Liebson PR. Relationships of quality-of-life measures to long-term lifestyle and drug treatment in the Treatment of Mild Hypertension Study. Arch Intern Med. 1997;157:638-648.
36. Kumanyika S. Behavioral aspects of intervention strategies to reduce dietary sodium. Hypertension. 1991;17(suppl I):190-195.
37. Intersalt Cooperative Research Group. Intersalt: an international study of electrolyte excretion and blood pressure: results for 24-hour urinary sodium and potassium excretion. BMJ. 1988;297:319-328.
38. Elliott P, Stamler J, Nichols R, Dyer AR, Stamler R, Kesteloot H, Marmot M. Intersalt revisited: further analyses of 24 hour sodium excretion and blood pressure within and across populations. BMJ. 1996;312: 1249-1253.
39. Stamler J. The INTERSALT Study, background, methods, findings, and implications. Am J Clin Nutr: 1997;65(suppl):626S-642S.
40. Stamler R, Shipley M, Elliott P, Dyer A, Sans S, Stamler J. Higher blood pressure in adults with less education: some explanations from INTERSALT. Hypertension. 1992;19:237-241.
41. Alderman MH, Madhavan S, Ooi WL, Cohen H, Sealey JE, Laragh JH. Low urinary sodium is associated with greater risk of myocardial infarction among treated hypertensive men. Hypertension. 1995;25:1144-1152.
42. Tunstall-Pedoe H, Woodward M, Tavendale R, Brook RA, McCluskey MK. Comparison of the prediction by 27 different factors of coronary heart disease and death in men and women of the Scottish Heart Health Study: cohort study. BMJ. 1997;315:722-729.
43. Alderman MH, Cohen H, Madhavan S. Dietary sodium intake and mortality: the National Health and Nutrition Examination Survey. Lancet. 1998;351:781-785.
44. Cook NR, Cutler JA, Hennekens CH. An unexpected result for sodium: causal or casual. Hypertension. 1995;25:1153-1154.
45. deWardener HE. Salt reduction and cardiovascular risk: the anatomy of a myth. J Hum Hypertens. 1999;13:1-4.
46. Cohen JD, Grandis G, Cutler JA, Neaton JD, Kuller LH, Stamler J. Dietary sodium intake and mortality: MRFIT Follow-up Study Results. Circulation. 1999;100(suppl I):I-524. Abstract.
47. Hunt SC, Cook NR, Oberman A, Cutler JA, Hennekens CH, Allender PS, Walker WG, Whelton PK, Williams RR. Angiotensinogen genotype, sodium reduction, weight loss, and prevention of hypertension. Hypertension. 1998;32:393B-401B.
48. Cirillo M, Laurenzi M, Panarelli W, Stamler J. Urinary sodium to potassium ratio and urinary stone disease: the Gubbio Population Study Research Group. Kidney Int. 1994;46:1133-1139.
49. Curhan GC, Willett WC, Speizer FE, Spiegelman D, Stampfer MJ. Comparison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk for kidney stones in women. Ann Intern Med. 1997;126:497-504.
50. Devine A, Criddle RA, Dick IM, Kerr DA, Prince RL. A longitudinal study of the effect of sodium and calcium intakes on regional bone density in postmenopausal women. Am J Clin Nutr. 1995;62:740-745.
51. Need AG, Morris HA, Cleghorn DB, De Nichilo D, Horowitz M, Nordin BE. Effect of salt restriction on urine hydroxyproline excretion in postmenopausal women. Arch Intern Med. 1991;151:757-759.
52. Carey OJ, Locke C, Cookson JB. Effect of alterations of dietary sodium on the severity of asthma in men. Thorax. 1993;48:714-718.
53. Lieberman D, Heimer D. Effect of dietary sodium on the severity of bronchial asthma. Thorax. 1992;47:360-362.
54. de Simone G, Devereux RB, Camargo MJF, Wallerson DC, Laragh JR. Influence of sodium intake on in vivo left ventricular anatomy in experimental renovascular hypertension. Am J Physiol. 1993;264:2103-2110.
55. Liebson PR, Grandits GA, Dianzumba S, Prineas RJ, Grimm RH, Neaton JD, Stamler J. Comparison of five antihypertensive monotherapies and placebo for change in left ventricular mass in patients receiving nutritional-hygienic therapy in the Treatment of Mild Hypertension Study (TOMHS). Circulation. 1995;91:698-706.
56. Egan BM, Stepniakowski KT. Adverse effects of short-term, very-low-salt diets in subjects with risk-factor clustering. Am J Clin Nutr. 1997;65(suppl):671S-677S.